New autism life skills room at FSU Panama City mimics real-world apartment living
Florida State University Panama City's Early Childhood Autism Program (ECAP) clinic celebrated the grand opening of its new autism life skills room with a ribbon cutting ceremony on April 17.
The space, designed to resemble a modern apartment, offers students a real-world environment to practice essential daily tasks such as cooking meals, using a dishwasher, using a washing machine and dryer, folding clothes and making a bed.
'This new furnished, mock apartment will allow us to teach a variety of living and learning, home-based skills,' Amy Pollick, associate dean of academic affairs and the development director for ECAP, said in a press release. 'Having this space will allow us to enhance the reach of our program to meet the needs of older children, teens and young adults.'
The project was made possible by a $100,000 donation from the Edward F. Hickey Jr. Memorial Trust, the press release stated. Hickey, a pioneer in the Panama City Beach business community beginning in the mid-20th century, died at age 94 in 2021.
The same trust has provided 'second chance' scholarships to FSU PC students from Panama City Beach and renovated the Fun Room at ECAP, in addition to supporting other local non-profits, including Backpack Blessings and the Bay County Public Library.
This article originally appeared on The News Herald: Families and staff applaud FSU PC's latest step toward independence for all students
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19-04-2025
- Yahoo
New autism life skills room at FSU Panama City mimics real-world apartment living
Florida State University Panama City's Early Childhood Autism Program (ECAP) clinic celebrated the grand opening of its new autism life skills room with a ribbon cutting ceremony on April 17. The space, designed to resemble a modern apartment, offers students a real-world environment to practice essential daily tasks such as cooking meals, using a dishwasher, using a washing machine and dryer, folding clothes and making a bed. 'This new furnished, mock apartment will allow us to teach a variety of living and learning, home-based skills,' Amy Pollick, associate dean of academic affairs and the development director for ECAP, said in a press release. 'Having this space will allow us to enhance the reach of our program to meet the needs of older children, teens and young adults.' The project was made possible by a $100,000 donation from the Edward F. Hickey Jr. Memorial Trust, the press release stated. Hickey, a pioneer in the Panama City Beach business community beginning in the mid-20th century, died at age 94 in 2021. The same trust has provided 'second chance' scholarships to FSU PC students from Panama City Beach and renovated the Fun Room at ECAP, in addition to supporting other local non-profits, including Backpack Blessings and the Bay County Public Library. This article originally appeared on The News Herald: Families and staff applaud FSU PC's latest step toward independence for all students

Associated Press
05-02-2025
- Associated Press
Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting
Presentations Included First Human Data on EVA™, Saluda's Automated SCS Programming Platform MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with chronic neurological conditions, today announced the presentation of new clinical data at the 2025 North American Neuromodulation Society (NANS) Annual Meeting, held from January 30 – February 1, 2025, in Orlando, FL. Data from 11 total abstracts and four oral presentations, two of which received the 'Top Oral Abstract' award, underscore the significance of objective neurophysiological measurements in spinal cord stimulation (SCS) with evoked compound action potential (ECAP) dose-controlled closed-loop therapy, and the potential clinical benefits of Saluda Medical's recently FDA-approved automated patient programming platform, EVA™. Highlights from EVA™ Automated Programming Abstract: 'Novel Automated Platform to Upgrade SCS Programming Experience from Subjective to Objective: Results from a Prospective, Dose-Controlled Closed-loop Clinical Study,' by Ajay Anthony, MD: 94% of all programming sessions using the automated programming platform successfully generated a closed-loop program <13-minute median time to generate each patient-specific automated program ≥90% of patients were satisfied or very satisfied with the automated programming platform experience Highlights from 'Top Oral Abstracts": 'ECAP Study Premiere: Real-World IDE Study Showing Relationship between Physiologic ECAP Biomarkers and Pain Outcomes,' by Jason Pope, MD: The ECAP IDE Study builds on the EVOKE IDE Study and represents the largest SCS study executed in a real-world cohort of 220 patients Real-world data demonstrated profound improvement (≥2 MCIDs) across all pain subgroups in the study including pain associated with Failed Back Surgery Syndrome, Non-Surgical Back Pain, Complex Regional Pain Syndrome, Diabetic Peripheral Neuropathy, and Upper Limb Pain 'Characterizing Spinal Cord Neurophysiology Using ECAP Dose-Controlled Closed-Loop SCS,' by Harold Nijhuis, MD: First SCS study to objectively characterize differences in cervical and thoracic spinal neurophysiology Significantly higher cervical SCS sensitivity may increase the risk of over- and under-stimulation when using open-loop SCS Precise dosing on a pulse-pulse basis using an ECAP dose-controlled closed-loop SCS may be necessary for durable long-term outcomes in the cervical spine 'Saluda is driving a pivotal moment in SCS, where advanced neurophysiological data and automation are redefining the standard of care,' said Jim Schuermann, President and CEO of Saluda Medical. 'We believe the next generation of SCS is here, and it's built on the foundation of objective science, precision, and personalized therapy that will continue to elevate patient care for years to come.' 'What stands out to me about these results is the newfound clarity in understanding the relationship between ECAP biomarkers and pain outcomes,' said Dr. Jason Pope, MD, Founder and CEO of Evolve Restorative Center. 'This real-world data from the largest SCS IDE study gives us confidence that tailored therapy with the Evoke System can significantly improve pain relief across multiple patient etiologies we treat in our practices. This kind of personalized, biomarker-driven therapy is leading to other breakthroughs such as predicting responders and non-responders to therapy and automation of programming to achieve the best relief for our patients.' The recognition of the Evoke® System at the 2025 NANS Annual Meeting highlights Saluda's commitment to advancing the field of neuromodulation through cutting-edge science and innovation. By combining real-world clinical evidence, objective biomarkers, and automation. Saluda is empowering clinicians to deliver more precise, personalized, and effective therapies for patients with chronic pain. These achievements underscore Saluda Medical's leadership in redefining SCS and its unwavering dedication to improving the lives of millions of patients. About Saluda Medical Saluda Medical is a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel neuromodulation platform. The Company's closed-loop, dose-control platform senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. The Company's first product, the Evoke® System, is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. 12-month results from the EVOKE study, the first and only prospective, multi-center, parallel-arm, double-blind, randomized controlled pivotal study with a voluntary crossover arm in SCS, that demonstrated clinically superior pain relief to open-loop therapy, were published in The Lancet Neurology, 24-month results were published in JAMA Neurology, and 36-month data, that demonstrated sustained pain relief, were published in Regional Anesthesia and Pain Medicine. To learn more, including risks and important safety information, visit Investor Contacts:
Yahoo
18-01-2025
- Yahoo
Hickey Trust donates to FSU Panama City Early Childhood Autism Program
PANAMA CITY, Fla. (WMBB) – A donation from the Edward F. Hickey Jr. Memorial Trust will provide a new element of constructive playtime for children at FSU Panama City's Early Childhood Autism Program (ECAP). According to a news release, $38,000 is going toward improvements in the ECAP Fun Room, including an enclosed activity area with slides, tunnels, and more. 'It's going to infuse new energy into the Fun Zone and provide excitement for our clients that can be used to fuel their individual progress,' ECAP Program Director Nikki Dickens said. Gulf World Marine Institute releases 4 cold-stunned sea turtles back into the Gulf The new Fun Zone play area will be unveiled at 10 a.m. on Wednesday, January 22 in the ECAP clinic at 4750 Collegiate Drive, Panama City. Hickey, a Panama City Beach business community pioneer since the mid-20th century, died in 2021. He owned and operated several businesses in Panama City Beach over the years, including Ed's Beach Services, which provided jobs and opportunities to generations of residents. Hickey continues to provide for Bay County's future. In 2024, the trust established an endowed scholarship at FSU Panama City; later this year an adult education component of the ECAP program, funded by the trust will open to provide life skills training. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.